Citadel — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Talaris Therapeuticstalaristx.comSep 2020

Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions

BiotechLouisville, US

Suzanne Ildstad(Executive Officer, Director)Scott Requadt(Executive Officer, Director)Geoff Mackay(Director)Francois Nader(Director)

Board Sandip Agarwala(Director)in Mark McDade(Director)in

Co-investorsAisling Capital Keyhorse Capital Longitude Capital Qiming Venture Partners USA Viking Global Blackstone Life Sciences +3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.